Literature DB >> 19680515

Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome.

Bill Ristevski1, Richard J Jenkinson, David J G Stephen, Joel Finkelstein, Emil H Schemitsch, Michael D McKee, Hans J Kreder.   

Abstract

BACKGROUND: It is considered that patients at risk for spontaneous fracture due to metastatic lesions should undergo surgical stabilization before fracture occurs; however, prophylactic stabilization is associated with surgical morbidity and mortality. We sought to compare pathological fracture fixation versus prophylactic stabilization of diaphyseal femoral lesions for patients with femoral metastases and assess the rate of prophylactic surgery completed in all regions of Ontario.
METHODS: Using population data sets, we identified all patients who had undergone femoral stabilization, either for pathological femoral fractures or for prophylactic fixation of femoral metastases before pathological fractures, between 1992 and 1997 in Ontario. We compared the rates of survival, serious medical and surgical complications and length of stay in hospital between the 2 groups.
RESULTS: A total of 624 patients underwent surgical stabilization for femoral metastases. The most common sites of primary metastases were the lungs (26%), breasts (16%), kidneys (6%) and prostate (6%); 46% of patients had other or multiple primary metastases. Overall, 37% of lesions were fixed prophylactically, with wide variation by region (17.6%-72.2%). Patients who underwent prophylactic stabilization had better overall survival at all postoperative time points. This held true after adjusting for age, sex, comorbidities and type of cancer (p < 0.001).
CONCLUSION: These data demonstrate a survival advantage with prophylactic fixation of metastatic femoral lesions combined with a relatively low perioperative risk excluding concomitant bilateral procedures. Ontario regional rates of prophylactic fixation vary enormously, with most patients not receiving prophylactic treatment.

Entities:  

Year:  2009        PMID: 19680515      PMCID: PMC2724796     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  23 in total

1.  Femoral metastatic fractures treated with intramedullary nailing.

Authors:  C E Gibbons; S J Pope; J P Murphy; A J Hall
Journal:  Int Orthop       Date:  2000       Impact factor: 3.075

Review 2.  Spine stats. The Cox regression analysis.

Authors:  J A Finkelstein; H Kreder
Journal:  Spine J       Date:  2001 Sep-Oct       Impact factor: 4.166

3.  Pressurization of the metastatic femur during prophylactic intramedullary nail fixation.

Authors:  Sandra E Roth; Mary M Rebello; Hans Kreder; Cari M Whyne
Journal:  J Trauma       Date:  2004-08

4.  Predicting fracture through benign skeletal lesions with quantitative computed tomography.

Authors:  Brian D Snyder; Diana A Hauser-Kara; John A Hipp; David Zurakowski; Andrew C Hecht; Mark C Gebhardt
Journal:  J Bone Joint Surg Am       Date:  2006-01       Impact factor: 5.284

5.  The effect of simulated metastatic lytic lesions on proximal femoral strength.

Authors:  Joyce H Keyak; Tadashi S Kaneko; Harry B Skinner; Bang H Hoang
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

Review 6.  Treatment of metastatic adenocarcinoma of the pelvis and the extremities.

Authors:  A D Aaron
Journal:  J Bone Joint Surg Am       Date:  1997-06       Impact factor: 5.284

7.  The incidence of acute cardiorespiratory and vascular dysfunction following intramedullary nail fixation of femoral metastasis.

Authors:  S A Barwood; J L Wilson; R R Molnar; P F Choong
Journal:  Acta Orthop Scand       Date:  2000-04

8.  Surgical treatment for pathologic fracture.

Authors:  R Wedin
Journal:  Acta Orthop Scand Suppl       Date:  2001-06

9.  Deep venous thrombosis after orthopedic surgery in adult cancer patients.

Authors:  P P Lin; D Graham; L E Hann; P J Boland; J H Healey
Journal:  J Surg Oncol       Date:  1998-05       Impact factor: 3.454

10.  Skeletal metastases.

Authors:  C S Galasko
Journal:  Clin Orthop Relat Res       Date:  1986-09       Impact factor: 4.176

View more
  24 in total

1.  CT-guided percutaneous screw fixation plus cementoplasty in the treatment of painful bone metastases with fractures or a high risk of pathological fracture.

Authors:  Claudio Pusceddu; Alessandro Fancellu; Nicola Ballicu; Rosa Maria Fele; Barbara Sotgia; Luca Melis
Journal:  Skeletal Radiol       Date:  2017-02-13       Impact factor: 2.199

Review 2.  Skeletal complications in cancer patients with bone metastases.

Authors:  Shunsuke Tsuzuki; Sun Hee Park; Matthew R Eber; Christopher M Peters; Yusuke Shiozawa
Journal:  Int J Urol       Date:  2016-08-03       Impact factor: 3.369

3.  Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease.

Authors:  Anas Nooh; Krista Goulding; Marc H Isler; Sophie Mottard; Annie Arteau; Norbert Dion; Robert Turcotte
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

4.  Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.

Authors:  Hung-Ming Lam; Holly M Nguyen; Eva Corey
Journal:  Methods Mol Biol       Date:  2018

5.  Local Infiltrative Analgesia is Equivalent to Fascia Iliaca Block for Perioperative Pain Management for Prophylactic Cephalomedullary Nail Fixation.

Authors:  Patrick Strotman; Taylor Reif; Cathleen Cahill; Cara Joyce; Lukas M Nystrom
Journal:  Iowa Orthop J       Date:  2021-12

6.  Comparison of percutaneous long bone cementoplasty with or without embedding a cement-filled catheter for painful long bone metastases with impending fracture.

Authors:  Xun-Wei Liu; Peng Jin; Kai Liu; Hao Chen; Li Li; Min Li; Hai Tang; Gang Sun
Journal:  Eur Radiol       Date:  2016-04-21       Impact factor: 5.315

7.  Reinforced cementoplasty using dedicated spindles in the management of unstable malignant lesions of the cervicotrochanteric region.

Authors:  Kévin Premat; Frédéric Clarençon; Raphael Bonaccorsi; Vincent Degos; Évelyne Cormier; Jacques Chiras
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

Review 8.  The effects of metastatic lesion on the structural determinants of bone: Current clinical and experimental approaches.

Authors:  Stacyann Bailey; David Hackney; Deepak Vashishth; Ron N Alkalay
Journal:  Bone       Date:  2019-11-21       Impact factor: 4.398

9.  A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.

Authors:  Omer Raheem; Anna A Kulidjian; Christina Wu; Young B Jeong; Tomonori Yamaguchi; Kristen M Smith; Daniel Goff; Heather Leu; Sheldon R Morris; Nicholas A Cacalano; Koichi Masuda; Catriona H M Jamieson; Christopher J Kane; Christina A M Jamieson
Journal:  J Transl Med       Date:  2011-10-28       Impact factor: 5.531

10.  Thirty-day Postoperative Complications After Surgery For Metastatic Long Bone Disease Are Associated With Higher Mortality at 1 Year.

Authors:  Bas J J Bindels; Quirina C B S Thio; Kevin A Raskin; Marco L Ferrone; Santiago A Lozano Calderón; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.